Wednesday, July 8, 2026
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
  • Politics
  • Lifestyle
  • Business
  • Medical
  • Shop
No Result
View All Result
No Result
View All Result
Home Politics

Bill to Legalize Marijuana Sales to Go Before Full Vermont Senate Vote

by Marijuana Moment
February 26, 2019
in Politics
0
Bill to Legalize Marijuana Sales to Go Before Full Vermont Senate Vote
0
SHARES
4
VIEWS
Share on FacebookShare on Twitter

A bill to tax and regulate marijuana in Vermont is heading to a vote before the full Senate in late February 2019 after clearing the latest in a string of committee victories Feb. 26.

Vermont became the first state in the U.S. to legalize marijuana in 2018 via legislative action, as opposed to by voters through a ballot measure. The law currently allows the possession of up to 1 ounce, or 28.35 grams, and the cultivation of two mature plants by adults. The state lacks a system to tax and regulate marijuana markets, however.

The specifics of how that system should be structured and operated has been the subject of discussion around two bills in the Legislature. H 196 has been backed by more than a third of the House’s members and has been referred to the House Committee on General, Housing and Military Affairs.

S 54 is a similar piece of legislation that would establish a Cannabis Control Board as the state’s regulatory body for a legal marijuana market and set up five types of licenses for various businesses. If approved by lawmakers and signed into law, the board would form on July 1, 2019, with licenses for retailers set to be issued on or before April 1, 2021.

The VT Senate is expected to vote (again!) on a retail marijuana bill Thursday. Here’s how it would play out, if passed. Sales could begin in 2021. #vtpoli pic.twitter.com/KeY7ffhT0q

— April McCullum (@april_mccullum) February 26, 2019

After previous approval in February 2019 in the Judiciary and Finance committees, the Senate Committee on Appropriations voted to advance the bill on Feb. 26. It now heads to the entire Senate floor, where a vote could come as early as Feb. 28.

A fiscal note issued by the Vermont Legislative Joint Fiscal Office disclosed cost estimates for the board as well as anticipated revenues from the Senate Judiciary Committee’s recommended 16 percent excise tax. Officials project a range of $3.8 million to $7.4 million in revenue in the first fiscal year and $8.6 million to $16.6 million by 2024.

For the recommended five-member Cannabis Control Board, the costs are estimated to be $860,000 in the 2020 fiscal year, $1,010,000 in 2021, and $940,000 in 2022.

Republican Gov. Phil Scott, who signed the state’s existing noncommercial cannabis legalization law, has said he would only consider approving legislation to tax and regulate marijuana sales if lawmakers fund education and prevention measures. He’s also expressed concerns about the lack of technology to detect impaired driving from cannabis.

The Senate has passed bills legalizing retail marijuana sales on three occasions while the House has so far been unable to do so.

Dave Silberman, an attorney and pro-bono drug policy drug reform advocate from Middlebury, said he’s feeling confident the bill will pass this time as well.

“With half the body already sponsoring the legislation, and the bill having been significantly improved in committee on important aspects like promoting equity in the cannabis industry, it’s pretty safe to predict that S 54 will easily pass the Senate with strong tri-partisan support,” he said. “Based on previous voting records, and what new Senators have said about cannabis regulation on the campaign trail, I expect anywhere from 24 to 26 ayes, with only 4 to 6 nays.”

Views: 555
Previous Post

Arizona Lawmakers Weigh Bill to Define Concentrates as Medical Cannabis

Next Post

Medical Cannabis Autism Treatments Now Legal in Colorado

Marijuana Moment

Related Posts

Inside the first week of the Marijuana Rescheduling Hearing

Inside the first week of the Marijuana Rescheduling Hearing

by Graham Cooper
July 6, 2026
0

It’s been a week of hearings the decide whether or not marijuana should be moved from Schedule I to Schedule...

Green Thumb Industries Marks Milestone as Second U.S. Cannabis Company Joins the NYSE

Green Thumb Industries Marks Milestone as Second U.S. Cannabis Company Joins the NYSE

by Keegan MacDonald
July 2, 2026
0

The Significance of Green Thumb Industries’ NYSE UplistingGreen Thumb Industries (GTI) will begin trading on the New York Stock Exchange...

How the Supreme Court’s Gun Rights Ruling is Shaping Marijuana User Cases Nationwide

by Keegan MacDonald
July 2, 2026
0

Breaking Down the Supreme Court’s Landmark DecisionIn a pivotal ruling, the U.S. Supreme Court has clarified the extent to which...

Marijuana Rescheduling Hearings Have Begun

Marijuana Rescheduling Hearings Have Begun

by Graham Cooper
June 29, 2026
0

Today, lawyers for the Drug Enforcement Administration have begun making the case for moving marijuana from Schedule I to Schedule...

Next Post
Medical Cannabis Autism Treatments Now Legal in Colorado

Medical Cannabis Autism Treatments Now Legal in Colorado

Inside the first week of the Marijuana Rescheduling Hearing

Inside the first week of the Marijuana Rescheduling Hearing

July 6, 2026
How Terpenes and Receptors Shape Cannabis’s Entourage Effect

How Terpenes and Receptors Shape Cannabis’s Entourage Effect

July 3, 2026
How Cannabis May Support Lower Back Pain Relief and Reduce Opioid Use

How Cannabis May Support Lower Back Pain Relief and Reduce Opioid Use

July 3, 2026
ADVERTISEMENT
Sign up for the PP Newsletter

Categories

  • Age Restrictions
  • Air Travel
  • All Categories
  • Animal Health
  • Anxiety Relief
  • Bioplastics
  • Bipartisan Politics
  • Business
  • Cancer Care
  • Cancer Treatment
  • Cannabinoid Receptors
  • Cannabinoids
  • cannabis
  • Cannabis Brands
  • Cannabis Culture
  • Cannabis Finance
  • Cannabis Industry
  • Cannabis Legalization
  • Cannabis Market
  • Cannabis Policy
  • Cannabis Reform
  • Cannabis Regulation
  • Cannabis Research
  • Cannabis Tourism
  • Cannabis Travel
  • CB1 Receptor
  • CB2 Receptor
  • CBD
  • Colorado
  • Congress
  • Congressional Amendment
  • Consumer Health
  • Criminal Justice
  • Culture
  • Deceptive Marketing
  • Democrats
  • Donald Trump
  • Drug Policy
  • Employment Law
  • Endocannabinoid System
  • Entourage Effect
  • Environment
  • Featured
  • Federal Cannabis Law
  • Federal Cannabis Policy
  • Federal Law
  • Federal Lawsuit
  • Glioblastoma
  • Green Thumb Industries
  • Gun Rights
  • Health Research
  • Hemp
  • Illegal Market
  • Investors
  • Job Loss
  • John Fetterman
  • Kratom
  • Law Enforcement
  • Lawmakers
  • Legal Cannabis Industry
  • Legal Compliance
  • Legal Precedent
  • Legislation
  • Lifestyle
  • Lower Back Pain
  • Marijuana
  • Marijuana Clemency
  • Marijuana Extracts
  • Marijuana Legalization
  • Marijuana Policy
  • Marijuana Reform
  • Marijuana Regulation
  • Marijuana Users
  • Medical
  • Medical Cannabis
  • Medical Claims
  • Medical Marijuana
  • MJBizDaily
  • MSOs
  • New Jersey
  • North Carolina
  • NYSE
  • Opioid Reduction
  • Packaging
  • Pain Management
  • Pets
  • Policy
  • Politics
  • Pre-rolls
  • Product Safety
  • Psychedelics
  • Public Education
  • Public Safety
  • Regulatory Challenges
  • Retail Strategy
  • Second Amendment
  • Sleep Disorders
  • State Cannabis Officials
  • State Legalization
  • Supreme Court
  • Sustainability
  • Symptom Management
  • Terpenes
  • Testosterone
  • THC
  • TSA
  • uncategorized
  • Uplisting
  • US Cannabis
  • US Cannabis Market
  • Veterans
  • Veterans Affairs
  • World Cup 2024
  • Young Men

Recent Posts

  • Inside the first week of the Marijuana Rescheduling Hearing
  • How Terpenes and Receptors Shape Cannabis’s Entourage Effect

Browse by Tag

420 cannabis Edibles Legalization marijuana NORML THC

AFFILIATES

© Pot Portal. All rights reserved.

No Result
View All Result

© Pot Portal. All rights reserved.